Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prolonged Versus Short Course of Indomethacin for the Treatment of Patent Ductus Arteriosus in Preterm Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434536/2/images/google-play-badge.png. Accessed 16 May 2024.
Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434536/2/images/google-play-badge.png. Accessed May 16, 2024.
Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434536/2/images/google-play-badge.png
Prolonged Versus Short Course of Indomethacin for the Treatment of Patent Ductus Arteriosus in Preterm Infants [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434536/2/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants
ID - 434536
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434536/2/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -